CN1986785A - Enzyme combining stabilizer - Google Patents

Enzyme combining stabilizer Download PDF

Info

Publication number
CN1986785A
CN1986785A CN 200510111883 CN200510111883A CN1986785A CN 1986785 A CN1986785 A CN 1986785A CN 200510111883 CN200510111883 CN 200510111883 CN 200510111883 A CN200510111883 A CN 200510111883A CN 1986785 A CN1986785 A CN 1986785A
Authority
CN
China
Prior art keywords
enzyme
grams
liquid
stabilizer
combining stabilizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510111883
Other languages
Chinese (zh)
Other versions
CN100434515C (en
Inventor
孙卫兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fosun diagnostic technology (Shanghai) Co.,Ltd.
Fosun diagnostic technology (Taizhou) Co., Ltd
Original Assignee
Shanghai Fosun Changzheng Medical Science Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Fosun Changzheng Medical Science Co Ltd filed Critical Shanghai Fosun Changzheng Medical Science Co Ltd
Priority to CNB2005101118834A priority Critical patent/CN100434515C/en
Publication of CN1986785A publication Critical patent/CN1986785A/en
Application granted granted Critical
Publication of CN100434515C publication Critical patent/CN100434515C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides a kind of efficient enzyme combining stabilizer with high stabilizing effect on enzymes for clinical diagnosis reagent. The enzyme combining stabilizer consists of bovine serum albumin, EGTA, 1, 2-dithio threitol, potassium gluconate, sodium chloride, proclin300, magnesium acetate, etc. It has powerful stabilizing effect on lactate dehydrogenase, sarcosie oxidase, urease, creatinine enzyme, creatine hydrolase, etc.

Description

Enzyme combining stabilizer
Technical field:
The invention belongs to biological technical field.Be specifically related to a kind of enzyme combining stabilizer.
Background technology:
Along with the development of medical career, the medical clinic applications field is progressively development, and various clinical diagnosis technologies further improve, and reagent for clinical diagnosis is constantly brought forth new ideas, for clinical diagnosis provides great help.Owing to be to be used for clinical diagnosis, the steady quality of this disconnected reagent of will seeing a doctor can prevent to cause mistaken diagnosis because of the reagent quality problem.Therefore, for the stability study of reagent for clinical diagnosis, listed the problem that people pay close attention in.But present reagent for clinical diagnosis quality both domestic and external is uneven, no matter from the specificity of reagent, or says in the sensitivity and all exists very big difference.And embodying particularly evidently as the important performance indexes-stability of diagnostic reagent. test kit often differs greatly in the test data in the production initial stage and the effect end of term. as the XX enzyme reagent kit, when detecting on December 9th, 2003, measured value is 286U/L, when detecting same sample on April 27th, 2004, measured value is 164 U/L, but have only 91 U/L when detecting on September 30th, 2004, measured value descends clearly, and these results will have a strong impact on clinical diagnosis.Tracing it to its cause is by due to the wherein used toolenzyme enzyme inactivation alive, seeks a kind of suitable enzyme stabilizers so and just seems extremely important.
Summary of the invention:
Technical problem to be solved by this invention is to overcome above-mentioned weak point, designs a kind of enzyme stabilizers, thereby plays the stable effect of enzymatic diagnosis reagent quality.
The invention provides a kind of efficient enzyme combining stabilizer.
Enzyme combining stabilizer of the present invention is made up of following components by weight ratio, counts with 1000 ml vols:
Bovine serum albumin 2 grams
EGTA (ethylene glycol diethyl ether ethylenediamine tetraacetic acid (EDTA)) or EDTA (ethylenediamine tetraacetic acid (EDTA)) 0.1~10 gram
1,2-dithiothreitol dithio 1~300 gram
Potassium Gluconate 10~200 grams
Sodium-chlor 2~100 grams
Proclin 300 (sanitas) 1 gram
Magnesium acetate or magnesium chloride 2~24 grams
In the above-mentioned prescription 1, the 2-dithiothreitol dithio also can use sucrose, mannitol or gsh to substitute.
Getting 5 milliliters of one package stabilizers of the present invention adds in 95 milliliters of various zymins, put 37 and spend baking ovens detect enzyme after 5 days activity. under the same conditions, detect and add one package stabilizer and do not add the work of the zymin of one package stabilizer, found that adding the remaining enzyme work of one package stabilizer is not add 2-10 times (the seeing instance data) that the enzyme of one package stabilizer is lived
Enzyme combining stabilizer of the present invention is prepared by following method:
The water that in container, adds 900 milliliters, the bovine serum albumin that adds specified volume more successively, EGTA (EDTA), 1,2-dithiothreitol dithio (sucrose, mannitol or gsh), Potassium Gluconate, sodium-chlor, proclin 300, and magnesium acetate (magnesium chloride) is treated to be settled to 1 liter after the dissolving fully.
Efficient enzyme combining stabilizer of the present invention is to galactenzyme desaturase, sarcosine oxidase, urase, Creatininase, creatine lytic enzyme, catalase, rCO, and flesh sterol esterase, peroxidation synthase all have very strong stabilising effect.
Description of drawings:
Fig. 1 is enzyme % alive, and is a control group, and ■ is for adding one package stabilizer.
Embodiment:
Example 1
Bovine serum albumin 2 grams
EGTA 4 grams
1,2-dithiothreitol dithio 25 grams
Potassium Gluconate 30 grams
Sodium-chlor 20 grams
Proclin300 1 gram,
Magnesium acetate 8 grams
Getting 5 milliliters of above-mentioned prozyme stablizers is added into 95 milliliters and contains serum lactic dehydrogenase (A liquid) respectively, sarcosine oxidase (B liquid), urase (C liquid), Creatininase (D liquid), creatine lytic enzyme (E liquid), catalase (F liquid), rCO (G liquid), Sterol esterase (H liquid) is in the zymin of peroxidase (I liquid), put 37 degree baking ovens after 5 days, detect remaining enzyme (comparing) (see figure 1) alive respectively with the zymin of not adding the prozyme stablizer
Example 2
Bovine serum albumin 2 grams
EDTA 10 grams,
Sucrose 1 gram
Potassium Gluconate 10 grams
Sodium-chlor 60 grams
Proclin300 1 gram
Magnesium chloride 24 grams
Getting 5 milliliters of above-mentioned prozyme stablizers is added into 95 milliliters and contains serum lactic dehydrogenase (A liquid) respectively, sarcosine oxidase (B liquid), urase (C liquid), Creatininase (D liquid), creatine lytic enzyme (E liquid), catalase (F liquid), rCO (G liquid), Sterol esterase (H liquid) is in the zymin of peroxidase (I liquid), put 2-8 degree refrigerator after 12 months, detect remaining enzyme (comparing) alive respectively with the zymin of not adding the prozyme stablizer
Table 1: remaining enzyme is lived and is contrasted
Figure A20051011188300061
Example 3
Bovine serum albumin 2 grams
EGTA 0.1 gram,
Mannitol 300 grams
Potassium Gluconate 183 grams
Sodium-chlor 100 grams
Proclin300 1 gram
Magnesium acetate 24 grams
Getting 5 milliliters of above-mentioned prozyme stablizers is added into 95 milliliters and contains serum lactic dehydrogenase (A liquid) respectively, sarcosine oxidase (B liquid), urase (C liquid), Creatininase (D liquid), creatine lytic enzyme (E liquid), catalase (F liquid), rCO (G liquid), Sterol esterase (H liquid) is in the zymin of peroxidase (I liquid), put 2-8 degree refrigerator after 12 months, detect remaining enzyme (comparing) alive respectively with the zymin of not adding the prozyme stablizer
Table 2: remaining enzyme is lived and is contrasted
Example 4
Bovine serum albumin 2 grams
EDTA 0.1 gram,
Gsh 120 grams
Potassium Gluconate 10 grams
Sodium-chlor 2 grams
Proclin300 1 gram
Magnesium chloride 2 grams
Getting 5 milliliters of above-mentioned prozyme stablizers is added into 95 milliliters and contains serum lactic dehydrogenase (A liquid) respectively, sarcosine oxidase (B liquid), urase (C liquid), Creatininase (D liquid), creatine lytic enzyme (E liquid), catalase (F liquid), rCO (G liquid), Sterol esterase (H liquid) is in the zymin of peroxidase (I liquid), put 2-8 degree refrigerator after 12 months, detect remaining enzyme (comparing) alive respectively with the zymin of not adding the prozyme stablizer
Table 3: remaining enzyme is lived and is contrasted

Claims (2)

1, a kind of enzyme combining stabilizer is characterized in that this enzyme combining stabilizer is made up of following components by weight ratio, counts with 1000 ml vols:
Bovine serum albumin 2 grams
EGTA or EDTA 0.1~10 gram
1,2-dithiothreitol dithio 1~300 gram
Potassium Gluconate 10~200 grams
Sodium-chlor 2~100 grams
Proclin 300 1 grams
Magnesium acetate or magnesium chloride 2~24 grams
In the above-mentioned prescription 1, the 2-dithiothreitol dithio also can use sucrose, mannitol or gsh to substitute.
2, a kind of enzyme combining stabilizer according to claim 1, it is characterized in that: this enzyme combining stabilizer is to serum lactic dehydrogenase, sarcosine oxidase, urase, Creatininase, creatine lytic enzyme, catalase, rCO, and flesh sterol esterase, peroxidation synthase all have very strong stabilising effect.
CNB2005101118834A 2005-12-23 2005-12-23 Enzyme combining stabilizer Active CN100434515C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005101118834A CN100434515C (en) 2005-12-23 2005-12-23 Enzyme combining stabilizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005101118834A CN100434515C (en) 2005-12-23 2005-12-23 Enzyme combining stabilizer

Publications (2)

Publication Number Publication Date
CN1986785A true CN1986785A (en) 2007-06-27
CN100434515C CN100434515C (en) 2008-11-19

Family

ID=38183729

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005101118834A Active CN100434515C (en) 2005-12-23 2005-12-23 Enzyme combining stabilizer

Country Status (1)

Country Link
CN (1) CN100434515C (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102162198A (en) * 2011-01-26 2011-08-24 申琳 Multienzyme complex preparation and preparation method and application thereof
CN102174758A (en) * 2011-01-26 2011-09-07 申琳 Method for preparing packaging material
CN102051352B (en) * 2009-11-02 2012-07-04 刘萍 Enzyme conjugate stabilizing solution
US8476050B2 (en) 2010-06-04 2013-07-02 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Conjugate preparation methods and related kit
CN103773833A (en) * 2013-12-19 2014-05-07 深圳市雷诺华科技实业有限公司 Creatinine measurement reagent
US8753858B2 (en) 2009-12-31 2014-06-17 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reagents and processes for stabilizing alkaline phosphatase or conjugates thereof
CN104198422A (en) * 2014-08-18 2014-12-10 苏州康铭诚业医用科技有限公司 Composite stabilizer for alpha-hydroxybutyric dehydrogenase assay kit
CN104198473A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Stable uric acid detection kit
CN104195222A (en) * 2014-08-18 2014-12-10 苏州康铭诚业医用科技有限公司 Compound stabilizer for total cholesterol measurement kits
US8940512B2 (en) 2010-06-04 2015-01-27 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processes for synthesizing alkaline phosphatase conjugates
CN104388531A (en) * 2014-10-20 2015-03-04 苏州康铭诚业医用科技有限公司 Compound stabilizer used for lactic dehydrogenase kit
CN104946616A (en) * 2015-05-12 2015-09-30 骏实生物科技(上海)有限公司 General solid stabilizer used for in vitro diagnostic reagent and application method of general solid stabilizer
CN106244672A (en) * 2016-08-19 2016-12-21 威海威仕泰医疗科技有限公司 A kind of stabilizer for uric acid detectable
CN106282308A (en) * 2016-08-29 2017-01-04 湖南海源医疗科技有限公司 A kind of in-vitro diagnosis biochemical reagents stabilizer
CN110261337A (en) * 2019-07-15 2019-09-20 三诺生物传感股份有限公司 A kind of total bile acid detection reagent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897346A (en) * 1986-07-15 1990-01-30 Beckman Instruments, Inc. Stabilized liquid enzyme composition for glucose determination
AU690144B2 (en) * 1994-10-17 1998-04-23 Argutus Intellectual Properties Limited Stabilising medium for alphaGST in urine for use in an enzyme immunoassay
AU760737B2 (en) * 1998-06-29 2003-05-22 Dsm Ip Assets B.V. Phytase formulation
CN100430487C (en) * 2002-11-15 2008-11-05 江西特康科技有限公司 Nicotinamide agent and preparation method thereof
CN1321180C (en) * 2004-04-09 2007-06-13 江南大学 Method for raising stability for preserving catalase prepared by microbiological method

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102051352B (en) * 2009-11-02 2012-07-04 刘萍 Enzyme conjugate stabilizing solution
US8753858B2 (en) 2009-12-31 2014-06-17 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reagents and processes for stabilizing alkaline phosphatase or conjugates thereof
US8940512B2 (en) 2010-06-04 2015-01-27 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Processes for synthesizing alkaline phosphatase conjugates
US8476050B2 (en) 2010-06-04 2013-07-02 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Conjugate preparation methods and related kit
CN102174758A (en) * 2011-01-26 2011-09-07 申琳 Method for preparing packaging material
CN102162198B (en) * 2011-01-26 2012-11-28 申琳 Multienzyme complex preparation and preparation method and application thereof
CN102174758B (en) * 2011-01-26 2013-02-13 申琳 Method for preparing packaging material
CN102162198A (en) * 2011-01-26 2011-08-24 申琳 Multienzyme complex preparation and preparation method and application thereof
CN103773833A (en) * 2013-12-19 2014-05-07 深圳市雷诺华科技实业有限公司 Creatinine measurement reagent
CN104198473A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Stable uric acid detection kit
CN104198473B (en) * 2014-08-14 2017-07-07 上海睿康生物科技有限公司 A kind of uric acid detection kit of stabilization
CN104198422A (en) * 2014-08-18 2014-12-10 苏州康铭诚业医用科技有限公司 Composite stabilizer for alpha-hydroxybutyric dehydrogenase assay kit
CN104198422B (en) * 2014-08-18 2017-04-19 苏州康铭诚业医用科技有限公司 Composite stabilizer for alpha-hydroxybutyric dehydrogenase assay kit
CN104195222A (en) * 2014-08-18 2014-12-10 苏州康铭诚业医用科技有限公司 Compound stabilizer for total cholesterol measurement kits
CN104388531A (en) * 2014-10-20 2015-03-04 苏州康铭诚业医用科技有限公司 Compound stabilizer used for lactic dehydrogenase kit
CN104946616A (en) * 2015-05-12 2015-09-30 骏实生物科技(上海)有限公司 General solid stabilizer used for in vitro diagnostic reagent and application method of general solid stabilizer
CN106244672A (en) * 2016-08-19 2016-12-21 威海威仕泰医疗科技有限公司 A kind of stabilizer for uric acid detectable
CN106282308A (en) * 2016-08-29 2017-01-04 湖南海源医疗科技有限公司 A kind of in-vitro diagnosis biochemical reagents stabilizer
CN110261337A (en) * 2019-07-15 2019-09-20 三诺生物传感股份有限公司 A kind of total bile acid detection reagent

Also Published As

Publication number Publication date
CN100434515C (en) 2008-11-19

Similar Documents

Publication Publication Date Title
CN100434515C (en) Enzyme combining stabilizer
Roth et al. The quantitative determination of galactose—an enzymic method using galactose oxidase, with applications to blood and other biological fluids
Takahashi et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase
CN105203472B (en) A kind of stable free fatty acid determination reagent kit
CN108949903B (en) Triglyceride determination kit and determination method thereof
CN102072953A (en) Method and kit for stably detecting sialic acid by enzyme method
WO2022068615A1 (en) Formulation for improving activity and/or thermostability of superoxide dismutases and use thereof
CN101503732A (en) Glucose oxidase single liquid detection reagent
CN104195222B (en) A kind of compound stabilizer for total cholesterol assay kit
CN105063174A (en) Serum glucose detection reagent
CN106929187B (en) A kind of cold water cold water detergent and preparation method thereof
CN106191211A (en) A kind of stabilizer for HDL-C detectable
CN108103142A (en) A kind of free-fat acid detection kit and preparation method thereof
CN106191206B (en) Free-fat acid detection kit and preparation method
JPH0670798A (en) Reagent composition for ulic acid measurement
JP2016508727A (en) Electrochemiluminescence (ECL) detection reagents and related methods for measuring enzyme activity
CN102994612A (en) Liquid monomer reagent for determining content of ammonia in blood serum, preparation method and application thereof
CN109541238A (en) Direct bilirubin detecting method and kit
Chrostek et al. Human alcohol dehydrogenase isoenzyme activity in the sera of non-alcoholic liver cirrhotic patients
JP2022033485A (en) Catalase
Costanzi et al. Lysosomal hydrolases in serum from human immunodeficiency virus-infected patients
JP2003116539A (en) Method for stabilizing ascorbic acid oxidase
JPH0474000B2 (en)
JPH11243950A (en) Fructosyl amino acid oxidase and its production
CN114964958B (en) Rifampicin sample preservation solution and application thereof in storage of rifampin blood sample or rifampin urine sample

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20170720

Address after: 200444 Shanghai city Baoshan District City Bank Road No. 830

Co-patentee after: Jiangsu Changxing Medical Technology Co Ltd

Patentee after: Shanghai Fosun Changzheng Medical Science Co., Ltd.

Address before: 200433 No. 995 Xiang Yin Road, Shanghai

Patentee before: Shanghai Fosun Changzheng Medical Science Co., Ltd.

TR01 Transfer of patent right
CP01 Change in the name or title of a patent holder

Address after: No. 830, Chengyin Road, Baoshan District, Shanghai 200444

Patentee after: Fosun diagnostic technology (Shanghai) Co.,Ltd.

Patentee after: Fosun diagnostic technology (Taizhou) Co., Ltd

Address before: No. 830, Chengyin Road, Baoshan District, Shanghai 200444

Patentee before: SHANGHAI FOSUN LONG MARCH MEDICAL SCIENCE CO.,LTD.

Patentee before: Jiangsu Changxing Medical Technology Co., Ltd

CP01 Change in the name or title of a patent holder